The Blue Box

Competitor Analysis

The traditional screening methods currently on the market are the mammogram, the MRI, and gene testing with BRCA biomarkers. However, none of these options are ideal compared to The Blue Box because they can become costly with annual check-ups or they are not specific enough for an accurate breast cancer result.

The Blue Box currently exhibits 90% accuracy compared to other forms of screening. It eliminates the fear of painful and unpleasant experiences with a simple urine sample in the comfort of the user's home.

---

Market Strategy

We strive to engage with potential customers throughout various social media platforms to publicize the efficacy and positive impact of our novel breast cancer screening device. We plan to launch a promotional video with anecdotes from real people, and highlight the struggles associated with breast cancer testing.

Who is The Blue Box for?
The Blue Box is for women who are choosing to be proactive in their own health. This is especially beneficial for women over the age of 40 who are predisposed or at a higher risk to develop breast cancer.

Subscription-based Service
The Blue Box’s subscription-based service is through an annual fee of $80 USD, or monthly installments of $7 USD. The user can keep the Blue Box device within their home and have access to The Blue App as long as they have an active subscription. They will receive periodic software updates as The Blue Box continues development.